www.yale.edu

PRISM's Homepage

Treatment Studies

Non-Treatment Studies

  Contact Information

links

  Publications

 


Program for Research in Smokers

with Mental Illness

(PRISM)


PRISM Smoking and Mental Illness Training Session Outline: 2004-2005

Tony P. George, M.D. and Jennifer C. Vessicchio, L.C.S.W.

Summary: This one-day training is geared to mental health and addiction providers and will familiarize participants with the epidemiology, neurobiology, clinical assessment of co-morbid nicotine dependence in the mentally ill, and to learning state-of-the-art intervention approaches for addressing nicotine and tobacco dependence in individuals with psychiatric and substance abuse disorders.

Target Audience(s): Psychiatrists, Internists, Psychologists, Social Workers, Nurses, Psychiatric Administrators and Other Mental Health Professionals.

Goals and Objectives:

1) To understand the epidemiology and neurobiology relevant to the co-morbidity of nicotine dependence in individuals with mental illness (psychiatric and substance abuse disorders).
2) To become familiar with a structured clinical evaluation for smokers with mental illness, including motivational assessments, determination of the presence and severity of nicotine dependence, assessments of psychiatric and substance abuse co-morbidity, and matching subsets of smokers to specific interventions.
3) To become familiar with approaches for the treatment of nicotine dependence in mentally ill patients, including treatment matching options using combinations pharmacological and behavioral interventions.
4) To develop strategies for implementing an integrated nicotine dependence management program in mental health and addiction treatment settings.

Curriculum Content:

1) Introductions and Training Goals and Objectives
2) Epidemiology of smoking and mental and addictive disorders
3) Biology of nicotine and tobacco
4) Etiological Models of Tobacco Addiction Vulnerability in the Mentally Ill
5) Clinical Evaluation of co-morbid nicotine dependence in mental illness
6) Structured Assessments of Interest: SCID-IV, FTND, ASI, MNWS, TQSU, Expired breath Carbon Monoxide, Smoking Timeline Follow-back (TLFB)
7) Approaches to Treatment of Nicotine and Tobacco Use in Mental Illness
8) Behavioral Approaches
9) Pharmacological Approaches
10) Combination of Behavioral and Pharmacological Treatment
11) Integration of Tobacco Addiction Treatment into Mental Health and Addiction Treatment Settings
12) Summary and Participant Discussion


Training Materials and Handouts:

George, T.P. and Vessicchio, J.C. (2001). Psychiatric Times. 18: 39-42.

George, T.P. and O'Malley, S.S. (2004). Trends Pharmacol. Sciences. 25: 42-48.

Ziedonis, D.M. and Williams, J.M. (2003). Current Opin. Psychiatry.

McChargue, D., Hitsman, B., Gulliver, S. (2002). Addiction, with Commentary by George and Vessicchio (2002) and others.

George, T.P. et al. (2000). Am. J. Psychiatry. 157: 1835-1842.

George, T.P., Vessicchio, J.C. et al. (2002). Biol. Psychiatry. 52: 53-61.

George, T.P., Vessicchio, J.C. et al. (2002). Neuropsychopharmacology. 26: 75-85.



 

Copyright © 2003 Program for Research for Smokers with Mental Illness

(PRISM), All Rights Reserved. Modified date: 12/08/2003